FUSE BIOTHERAPEUTICS
Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner such that potent responses to danger are targeted without sacrificing natural breaks in the system that spare healthy tissues. Fuse Biotherapeutics was founded in 2021 and is headquartered in Los Angeles, CA.
FUSE BIOTHERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2021-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.fusebiotx.com
Status:
Active
Contact:
3109918254
Email Addresses:
[email protected]
Total Funding:
9.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail GoDaddy DNS GStatic Google Static Content
Similar Organizations
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Current Employees Featured
Founder
Investors List
Sherpa Venture Capital
Sherpa Venture Capital investment in Seed Round - Fuse Biotherapeutics
Sirona Capital
Sirona Capital investment in Seed Round - Fuse Biotherapeutics
GC&H Investments
GC&H Investments investment in Seed Round - Fuse Biotherapeutics
Viva BioInnovator
Viva BioInnovator investment in Seed Round - Fuse Biotherapeutics
Ivy Venture Group
Ivy Venture Group investment in Seed Round - Fuse Biotherapeutics
Official Site Inspections
http://www.fusebiotx.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Fuse Biotherapeutics"
About us | Home
Fuse Biotherapeutics is developing novel immunotherapies for cancer. Our therapeutics are focused on IL-18, a powerful hormone-like protein that is released in response to danger such as cancer to stimulate the immune …See details»
Fuse Biotherapeutics - Crunchbase Company Profile
Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers. The company's therapeutic …See details»
Fuse Biotherapeutics Company Profile 2024: Valuation, Funding ...
Fuse Biotherapeutics General Information Description. Developer of immune-modulating therapeutics designed to treat cancers effectively. The company platform offers a therapeutic …See details»
Fuse Biotherapeutics - LinkedIn
Fuse Biotherapeutics | 674 followers on LinkedIn. Directing and Potentiating our Immune System | At FuseBio, we are dedicated to developing transformative immune modulating therapeutics …See details»
Contact | Home
Contact | Home ... FuseBio ContactSee details»
Fuse Biotherapeutics - Craft
Fuse Biotherapeutics has 5 employees at their 1 location and $9.5 m in total funding,. See insights on Fuse Biotherapeutics including office locations, competitors, revenue, financials, …See details»
Fuse Biotherapeutics
Empowering Immunity, Defying Cancer ResistanceSee details»
Fuse Biotherapeutics - workinbiotech.com
Fuse Biotherapeutics is developing immune-modifying therapies to treat cancer. Immune responses consist of multiple steps to ensure that it effectively deals with various situations …See details»
Fuse Biotherapeutics Raises an Oversubscribed and Upsized Seed ...
Nov 15, 2021 "As Brian Rabinovich, Ph.D., Jeffrey Takimoto, Ph.D., Evren Alici, MD, Ph.D., and I virtually launched FuseBio during the height of the pandemic, we are very pleased ...See details»
Fuse Biotherapeutics Raises an Oversubscribed and Upsized Seed ...
Nov 15, 2021 www.fusebiotx.com. About Viva BioInnovator. As the investment division of Viva Biotech, Viva BioInnovator is dedicated to investing globally in biotech innovation with novel …See details»
Fuse Biotherapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Fuse Biotherapeutics - Viva BioInnovator
Viva BioInnovator. No. 50, Lane 63, Faraday Road, Zhangjiang High-Tech Park, Shanghai, 201203, China.See details»
Fuse Biotherapeutics - Company Profile - Tracxn
Nov 13, 2024 Fuse Biotherapeutics ranks 970th among 2425 active competitors. 872 of its competitors are funded while 557 have exited. Overall, Fuse Biotherapeutics and its …See details»
Viva BioInnovator
Www.fusebiotx.com. About Viva BioInnovator. As the investment division of Viva Biotech, Viva BioInnovator is dedicated to investing globally in biotech innovation with novel solutions to …See details»
Pipeline | Home
Developing a pipeline around our first in class IL-18 variant, F-18, that can be added to both existing and new therapeutics in a “plug and play” manner.See details»
Platform | Home
Interleukin-18 (IL-18) is a potent multi-functional cytokine known for its robust immunostimulatory effects. Its profound and vast biological influence extends beyond immune activation; it can …See details»
FuseBio Presents New Data at AACR: Targeting a Functionally
FuseBio's unique attenuation mechanism renders IL-18, a functionally selective IL-18, resistant to IL-18BP and 1 million percent less active in circulation...See details»
Fuse Biotherapeutics Raises an Oversubscribed and Upsized Seed ...
Www.fusebiotx.com. About Viva BioInnovator. As the investment division of Viva Biotech, Viva BioInnovator is dedicated to investing globally in biotech innovation with novel solutions to …See details»
2024.04.09 AACR Poster Presentation | Home
Apr 9, 2024 The abstract will be made available for viewing on FuseBio’s website upon presentation at the AACR 2024 Annual Meeting (www.fusebiotx.com). About Fuse …See details»
Papers & Publications | Home - fusebiotx.com
Nov 5, 2022 FuseBio Papers & PublicationsSee details»